Magnetic Seizure Therapy (MST)*: Research Fundamentals and Applications workshop
MagVenture is hosting a workshop as part of the program at International Brain Stimulation Conference. If you plan to attend the conference, register now to listen to some of the top pioneers within the newest research in MST*: Prof. André Brunoni, Prof. Jijun Wang, and Prof. Kodaka.
3 hours of overviews, newest clinical research results and a panel debate on the future of Convulsion Treatment with Magnetic Seizure Therapy (MST)*.
Ask questions and see live the MST* research system – the MagPro XP Black Edition (MST), the most powerful, advanced, and tailored system for the application of MST.
*Please note that the MST (Magnetic Seizure Therapy) device showcased during this workshop is intended exclusively for research purposes
When: February 23rd, 2025, from 9:00 am to 12:30 pm.
Where: Room 501, Kobe conference centre.
Workshop program coming soon.
Speakers:
Prof. Andre Brunoni
Andre Brunoni is an Associate Professor of the Department of Psychiatry of the University of São Paulo Medical School, visiting professor of the University of Munich, and Chief of the Interventional Psychiatry group of the Institute of Psychiatry of the Clinics Hospital of the University of São Paulo. He is Deputy Editor of Psychiatry of the Brain Stimulation journal, and Editor-in-Chief of the Brazilian Journal of Psychiatry. Dr. Brunoni has published more than 400 articles in peer-reviewed journals, some of them in leading journals such as the New England Journal of Medicine, Lancet, and JAMA Psychiatry, presenting 31,000 citations and an H-index of 78 according to Google Scholar. His work has been funded by competitive Brazilian grant agencies and international institutions such as NIMH, Brain and Behavior Research Foundation, Milken Institute, Stanley foundation, FWO and Alexander von Humboldt Foundation.
Prof. Jijun Wang
Wang Jijun is Chief Psychiatrist, Director of Department of Clinical Neurophysiology at National Mental Illness Center and Shanghai Mental Health Center, Doctoral Supervisor in Shanghai Jiaotong University School of Medicine, Visiting Researcher at the Brain Science and Intelligent Technology Excellence Innovation Center of the Chinese Academy of Sciences, PI at Shanghai Key Laboratory of Psychotic Disorders, Member of the Psychiatric Basic and Clinical Branch of the Neuroscience Society, Vice Chairman of the EEG and Clinical Neuroelectrophysiology Branch of the Shanghai Medical Association, and Editorial Board Member of academic journal of Schizophrenia Research, etc.
Was selected for Shanghai Pujiang Talent Program in 2006, Outstanding Academic Leader in Shanghai in 2016, and “Outstanding Psychiatrist” of the Psychiatrist Branch of the Chinese Medical Association in 2022.
Prof. Fumitoshi Kodaka
Fumitoshi Kodaka is an associate professor in the Department of Psychiatry at The Jikei University School of Medicine and deputy director of the Department of Psychiatry at The Jikei University Hospital. He is the principal investigator of Advanced Medical Treatment by the Ministry of Health, Labour, and Welfare into the maintenance rTMS for treatment-resistant depression, and low-frequency rTMS for bipolar depression at The Jikei University Hospital. He is a visiting researcher at the National Center of Neurology and Psychiatry, Integrative Brain Imaging Center (IBIC) and the National Institute of Mental Health, Department of Pathophysiology of Mental Disorders, and a chief researcher at the Institute of Social Psychiatry, Sobu Hospital, Fukko-kai Foundation. He has published extensively in top journals using research methods using structural/functional MRI and positron emission tomography. He is a council member of both The Japanese Society of Neuropsychopharmacology and the Japanese Society of Mood Disorders, and has been involved in the formulation of treatment guidelines for depression and schizophrenia in Japan.
